<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00407290</url>
  </required_header>
  <id_info>
    <org_study_id>CE 2005/13mai/87</org_study_id>
    <nct_id>NCT00407290</nct_id>
  </id_info>
  <brief_title>The Impact of an Epidural Ropivacaine-Neostigmine Injection for Perineal Analgesia at the End of Labor.</brief_title>
  <official_title>The Impact of an Epidural Ropivacaine-Neostigmine Injection for Perineal Analgesia at the End of Labor, on Either Immediate Postpartum Perineal Pain or Development of Chronic Perineal Pain After Vaginal Delivery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <brief_summary>
    <textblock>
      Perineal pain after childbirth occurs in the majority of women (with or without episiotomy).
      Perineal pain can become source of chronic pain in 9%-12% of the cases. Neostigmine a
      cholinesterase inhibitor at a dose of 500µg combined with Sufentanil or Ropivacaine (=local
      anaesthetic) is an analgesic. The goal of this study is to examine the effect of the use of
      epidural Neostigmine for perineal analgesia at the end of the labor on acute pain and on the
      development of chronic pain post partum.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of epidural analgesia during labour is to obtain an analgesia with a minimum of
      “motor block”. Absence of motor block at the time of the childbirth allows to decrease the
      rate of instrumentation (forceps, vacuum extractor). When the parturient approach complete
      cervical dilatation (8-10 cm), the anaesthetist must perform a last epidural injection for
      perineal analgesia. Generally a local anaesthetic is used (ex : Ropivacaine). Adjuvant can be
      associated to local anaesthetic (Sufentanil, Clonidine and more recently Neostigmine) to
      maximize local anaesthetic without increasing motor block.

      Neostigmine, a cholinesterase inhibitor, increase concentration of acetylcholine on synaptic
      level and stimulate analgesic mechanisms mediated by this acetylcholine on dorsal horn of
      spinal cord.

      Perineal pain after childbirth appears in most of the women with or without episiotomy. (Mac
      Arthur Am J Obst. Gynecol. 2004). This perineal pain can become source of chronic pain in
      9%-12% of the cases. Neostigmine, a cholinesterase inhibitor at the dose of 500µg, combined
      with Sufentanil or Ropivacaine (=local anaesthetic) has an analgesic effect.

      The goal of this study is to examine the effect of epidural Neostigmine for perineal
      analgesia at the end of the labour and on the development of chronic pain post-partum.

      Inclusion criteria : any parturient of 18-45 years, normal pregnancy, at full term and having
      an effective epidural anaesthesia during labour.

      Exclusion criteria : multiple pregnancy, obstetric pathology, refusal of participation.

      Randomisation : 2 groups of 30 patients

      Method :

      Installation of the epidural catheter :

      - Injection of Ropivacaïne + Sufentanil

      Perineal analgesia :

        -  Ropi Group : epidural injection of Ropivacaine

        -  Neostigmine Group : epidural injection of Ropivacaine and Neostigmine

      Evaluation of VAS, vital signs of parturient and fetal heart rate, instrumentation rate.

      Evaluation of immediate post-partum pain (48hours) and use of analgesic medication in the
      ward.

      Evaluation of chronic pain after 10 days and 1 month.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2006</start_date>
  <completion_date>October 2006</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>acute pain (VAS)</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>chronic pain (questionnaire)</measure>
  </primary_outcome>
  <enrollment>60</enrollment>
  <condition>Pregnancy</condition>
  <condition>Vaginal Delivery</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>neostigmine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  any parturient of 18-45 years

          -  normal pregnancy

          -  at full term

          -  having an effective epidural anesthesia during labor

        Exclusion Criteria:

          -  multiple pregnancy

          -  obstetric pathology

          -  refusal of participation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabienne Roelants, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cliniques universitaires Saint-Luc</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fabienne Roelants, MD</last_name>
    <phone>02 764 18 21</phone>
    <phone_ext>anes</phone_ext>
    <email>Fabienne.Roelants@anes.ucl.ac.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Patricia Lavand'homme, MD, PhD</last_name>
    <phone>02 764 18 21</phone>
    <phone_ext>anes</phone_ext>
    <email>lavandhomme@anes.ucl.ac.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cliniques Universitaires Saint Luc</name>
      <address>
        <city>Brussels</city>
        <state>Brusssels</state>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>December 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2006</study_first_submitted>
  <study_first_submitted_qc>December 4, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 5, 2006</study_first_posted>
  <last_update_submitted>December 4, 2006</last_update_submitted>
  <last_update_submitted_qc>December 4, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 5, 2006</last_update_posted>
  <keyword>pregnancy</keyword>
  <keyword>vaginal delivery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Neostigmine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

